Page 2 - Johnson And Johnson

J&J's Covid-19 vaccine reviewed by EU regulator after blood clots

One of the cases following J&J vaccinations happened during a clinical trial.

J&J in talks with Centre for trial of single-shot Covid-19 vaccine

Russia's Sputnik V is another contender to get approval from the Indian drug regulator

US puts J&J in charge of plant that botched vaccine, removes AstraZeneca

US puts J&J in charge of plant that botched vaccine, removes AstraZeneca

France imposes third lockdown amid rising Covid-19 cases, schools closed

The French leader implored the nation to make an extra effort as the lockdown comes into force on Saturday

J&J 'under stress' to meet EU second-quarter vaccine supply goal: Report

BRUSSELS (Reuters) - Johnson & Johnson has told the European Union it is facing supply issues that may complicate plans to deliver 55 million doses of its COVID-19 vaccine to the bloc in the second quarter of the year, an EU official told Reuters.

J&J CEO sees Covid-19 shots in American arms in 1-2 days as shipping starts

(Reuters) - Johnson & Johnson's newly authorized COVID-19 vaccine has started shipping and its top executive said on Monday that Americans should be able to receive the single-dose shot within the next 24 to 48 hours, adding a third vaccine in the United States.

US authorises J&J's single-dose Covid-19 vaccine for emergency use

Shipments to vaccination sites are expected to begin on Sunday or Monday

New Covid vaccines: Here's how Novavax and Johnson & Johnson jabs work

Both of these vaccines share some similarities with those already being delivered, but they also have some notable differences

Aspen Pharmacare, Johnson & Johnson announce deal to make Covid-19 vaccine

South African pharmaceutical firm Aspen Pharmacare has announced a deal with U.S. firm Johnson & Johnson to manufacture its COVID-19 vaccine candidate, if it is approved in South Africa and internationally. In a statement issued on Monday, Aspen said that if ongoing trials bring international health authorities to endorse the J&J vaccine as effective and safe, it would be produced at Aspen's manufacturing facility in Port Elizabeth in South Africa's Eastern Cape province. The company said the facility has a capacity to manufacture more than 300 million doses of the vaccine a year. Johnson & Johnson's test vaccine, Ad26.COV3-S, is one of four different vaccines currently undergoing clinical trials in South Africa. Johnson & Johnson would be responsible for supplying the vaccine in large batches and Aspen would put it into vials and package it for individual doses, pending a final commercial agreement, said the statement issued by Aspen. Aspen chief executive Stephen ...

Johnson & Johnson, AstraZeneca to resume trial for Covid-19 vaccine

Earlier, AstraZeneca said it had been cleared by the FDA to restart a trial that had been halted in the U.S. after a volunteer participating in a U.K. trial of the shot had fallen ill

Spain to begin clinical trials of Johnson & Johnson Covid-19 vaccine today

Spain's first trials of a coronavirus vaccine are scheduled to begin on Monday, Alberto Borobia, the chief of the clinical trials unit of the La Paz University Hospital in Madrid, said on Sunday.The vaccine to be tested was developed by US corporation Johnson & Johnson. Phase 1 trials were held in the United States and Belgium. The trials in Spain will fall under Phase 2, to be also held in Germany and Belgium.Three Spanish hospitals will be administering the trials -- the Marques de Valdecilla hospital in Santander will launch then on Monday and the La Paz and La Princesa university hospitals in Madrid will join in on Tuesday, according to Borobia.The expected pool of participants includes 190 volunteers, of which La Paz University Hospital's share will be 50 adults aged 18-55 and 25 seniors aged over 65, Borobia told Spanish news agency Servimedia.The participants will get either one shot of the vaccine or two shots a month apart. There will also be a group that will be given .

J&J seeking 20,000 Covid vaccine trial volunteers in hard-hit Latin America

SANTIAGO (Reuters) - Johnson & Johnson will seek 20,000 volunteers for late-stage human trials of its experimental coronavirus vaccine in hard-hit Latin America, one-third of the planned global total, one of its public health chiefs in the region said.

EU concludes talks on potential coronavirus vaccine supply from J&J

The European Commission has announced that it concluded exploratory talks with Johnson & Johnson to purchase a potential vaccine against COVID-19.

EU negotiating with drugmakers to secure potential Covid-19 vaccines

The talks follow a deal reached in June by four EU member states with AstraZeneca for the upfront purchase of 400 million doses of its potential Covid-19 vaccine

Coronavirus update: Lockdown 4.0, Vande Bharat Mission and other stories

Air India and its subsidiary Air India Express operated a total of 14 flights on Tuesday to bring back Indians under the Vande Bharat Mission and for travel of foreigners amid the lockdown

NAA fines J&J Rs 230 crore for profiteering from cut in GST rates

"The methodology adopted by the respondent (J&J) was illogical, unreasonable, arbitrary, and incorrect", the order said

Johnson & Johnson wins 4th verdict in a row, cleared in US baby powder case

The baby powder of Johnson & Johnson is not responsible for a Missouri woman's cancer, a jury in the US has decided in the company's latest win in a litigation case over its famous product. The litigation case (Forrest) in St Louis, Missouri in the US has resulted in a verdict for Johnson & Johnson, finding Johnson's baby powder was not the cause of the Vickie Forrest's disease. "This is the fourth consecutive verdict in favour of Johnson & Johnson in these cases and the eighth defense verdict this year," a Johnson & Johnson company spokesperson said in a statement. The jury carefully considered the decades of independent clinical evidence, which show Johnson's Baby Powder is safe, does not contain asbestos, and does not cause cancer, it added. "We know that anyone suffering from cancer is searching for answers, which is why the science and facts on this topic are so important," the statement said.

Drug inspectors seize J&J baby product samples from wholesalers, retailers

The CDSCO, under the Union Health Ministry, said a team of 100 drug inspectors have been deployed for this purpose

J&J faulty hip implant compensation: Age, risk factor may be considered

Based on the slabs, the amount could vary from Rs 3 million to as much as Rs 12 million

Faulty hip implants: Govt's nod soon for compensation formula on J&J

The company said it had reached out to doctors to let patients know of the compensation programme